Medication-induced sleep disturbances

Consultant Pharmacist

Volumn 26, Issue 6, 2011, Pages 414-425

  Foral, Pamela ^a   Knezevich, Jon ^a   Dewan, Naresh ^b,c   Malesker, Mark ^d  

^a CREIGHTON UNIVERSITY SCHOOL OF PHARMACY AND HEALTH PROFESSIONS   (United States)

^b Department of Internal Medicine   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d CREIGHTON UNIVERSITY   (United States)

Author keywords

Insomnia; Nightmares; Periodic limb movements; Sedation; Sleep architecture; Sleep attacks; Sleep disturbances

Indexed keywords

ACEBUTOLOL; ALPHA INTERFERON; ATENOLOL; CARBAMAZEPINE; CITALOPRAM; CLINDAMYCIN; CLONIDINE; DULOXETINE; ESCITALOPRAM; ETHOSUXIMIDE; FLUOXETINE; FLUVOXAMINE; LABETALOL; METHYLDOPA; METOPROLOL; NADOLOL; PAROXETINE; PHENELZINE; PHENOBARBITAL; PHENYTOIN; PINDOLOL; PROPRANOLOL; RISPERIDONE; SERTRALINE; SOTALOL; TIMOLOL; TRAMADOL; TRAZODONE; UNINDEXED DRUG; VALPROIC ACID; PRESCRIPTION DRUG;

DREAMING; DRUG INDUCED DISEASE; EATING DISORDER; HALLUCINATION; HUMAN; INSOMNIA; MEDLINE; NIGHTMARE; PARASOMNIA; PERIODIC LIMB MOVEMENT DISORDER; PHARMACIST; POLYSOMNOGRAPHY; PRACTICE GUIDELINE; PRESCRIPTION; RESTLESS LEGS SYNDROME; REVIEW; SEDATION; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP PATTERN; SLEEP WALKING; WEIGHT GAIN; CHEMICALLY INDUCED;

HUMANS; PRESCRIPTION DRUGS; SLEEP DISORDERS;

EID: 80051559993     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2011.414     Document Type: Review

References (60)

1. Foral PA, Hopkins H, Holstein S et al. Medications as a cause of sleep disturbances. Consult Pharm 2002;17:417-26.
2. Johnson E. Epidemiology of insomnia: from adolescence to old age. Sleep Med Clin 2006;1:305-17.
3. Obermeyer WH, Benca RM. Effects of drugs on sleep. Neurol Clin 1996;14:827-40. (Pubitemid 26357675)
4. Meyer T. Evaluation and management of insomnia. Hosp Pract 1998:75-86.
5. Stradling JR. ABC of sleep disorders. Recreational Drugs and Sleep. BMJ 1993;306:573-5.
6. Thomson Reuters I. Micromedex Healthcare Series. Available at http://thomsonreuters.com/products-services/healthcare/healthcare-products/ clinical-deci-support/micromedex-clinical-evidence-sol/. Accessed August 26, 2010.
7. Cender D, Gelhot A, Phillips B et al. Daytime drowsiness: is a drug to blame? J Respir Dis 1998;19:617-29.
8. Eisen J, MacFarlane J, Shapiro CM. ABC of sleep disorders. Psychotropic drugs and sleep. BMJ 1993;306:1331-4.
9. Schweitzer PK. Drugs that disturb sleep and wakefulness. In Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. 3rd ed. Philadelphia, PA: WB Saunders Company; 2000:441-61.
10. Bazil CW. Nocturnal seizures and the effects of anticonvulsants on sleep. Current Neurol Neurosci Rep 2008;8:149-54. (Pubitemid 351460248)
11. Pandharipande P, Ely EW. Sedative and analgesic medications: risk factors for delirium and sleep disturbances in the critically ill. Crit Care Clin 2006;22:313-27.
12. Thase M. Treatment issues related to sleep and depression. J Clin Psychiatry 2000;61:46-50. (Pubitemid 30616695)
13. Attarian H. Helping patients who say they cannot sleep, practical ways to evaluate and treat insomnia. Postgrad Med 2000;107:127-42. (Pubitemid 30158501)
14. Pascoe P. Drugs and the sleep-wakefulness continuum. Pharmacol Ther 1994;61:227-36.
15. Armitage R. The effects of antidepressants on sleep in patients with depression. Can J Psychiatry 2000;45:803-9. (Pubitemid 32094970)
16. Feighner J. Mechanism of action of antidepressant medications. J Clin Psychiatry 1999;60:4-11.
17. Monti JM, Monti D. Sleep in schizophrenia patients and the effects of antipsychotic drugs. Sleep Med Rev 2004;8:133-48. (Pubitemid 38445488)
18. Manber R, Armitage R. Sex, steroids, and sleep: a review. Sleep 1999;22:540-55. (Pubitemid 29379112)
19. Novak M, Shapiro CM. Drug induced sleep disturbances. Drug Safety 1997;16:133-48.
20. Idzikowski C, Shapiro CM. ABC of sleep disorders. Non-psychotropic drugs and sleep. BMJ 1993;306:1118-21.
21. Pagel JF. Diagnosis and treatment of insomnia. Am Fam Physician 1987;35:191-7.
22. Dimsdale JE, Norman D, DeJardin D et al. The effect of opioids on sleep architecture. J Clin Sleep Med 2007;3:33-6. (Pubitemid 46761006)
23. Murphy PJ, Badia P, Myers BL et al. Nonsteroidal antiinflammatory drugs affect normal sleep patterns in humans. Physio Behav 1994;55:1063-6. (Pubitemid 24168765)
24. Gallego L, Barreiro P, del Rio R, et al. Analyzing sleep abnormalities in HIV-infected patients treated with efavirenz. Clin Infect Dis 2004;38:430-2. (Pubitemid 38200124)
25. Cooke JR, Loredo JS, Liu L et al. Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease. Drugs Aging 2006;23:503-11. (Pubitemid 44162304)
26. Gutierrez-Valencia A, Viciana P, Palacios R et al. Stepped-dose versus full-dose efavirenz for HIV infection and neuropsychiatric adverse events. Ann Intern Med 2009;151:149-56.
27. Micallef J, Rey M, Eusebio A et al. Antiparkinsonian druginduced sleepiness: a double-blind placebo controlled study of L-DOPA, bromocriptine, and pramipexole in healthy subjects. Br J Clin Pharmacol 2008;67:333-40.
28. Chaudhuri KR, Pal S, Brefel-Courbon C. Sleep attacks or unintended sleep episodes occur with dopamine agonists. Drug Safety 2002;25:476-83.
29. Ferreira JJ, Galitzky M, Thalamas C et al. Effect of ropinirole on sleep onset: a randomized, placebo-controlled study in healthy volunteers. Neurology 2002;58:341-6.
30. Ulivelli M, Rossi S, Lombardi C et al. Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD. Neurology 2002;58:462-5. (Pubitemid 34150925)
31. Ziegenbein M, Held K, Kuenzel HE et al. The somatostatin analogue octreotide impairs sleep and decreases EEG sigma power in young male subjects. Neuropsychopharmacology 2004;29: 146-51. (Pubitemid 38068024)
32. Hoque R, Chesson AL Jr. Pharmacologically induced/exacerbated restless leg syndrome, periodic limb movement/REM sleep without atonia: literature review, qualitative scoring and comparative analysis. J Clin Sleep Med 2010;6:79-83.
33. Bermejo PE. Restless legs syndrome induced by topiramate: two more cases. J Neurol 2009;256:662-3.
34. Chen JT, Garcia PA, Aldredge BK. Zonisamide-induced restless legs syndrome. Neurology 2003;60:147. (Pubitemid 36070669)
35. Wetter TC, Brunner J, Bronisch T. Restless legs syndrome probably induced by risperidone treatment. Pharmacopsychiatry 2002;35:109-11. (Pubitemid 34651917)
36. LaRochelle JS, Karp BI. Restless legs syndrome due to interferon-alpha. Movement Disord 2004;19:730-1. (Pubitemid 39173037)
37. Velasco PEB, Goiburu JAZ, Pine RS. Restless legs syndrome induced by zonisamide. Movement Disord 2007;22:1517-8. (Pubitemid 47280649)
38. Pagel JF. Drugs, dreams and nightmares. Sleep Med Clin 2010;5:277-87.
39. Gregoor PJHS. Atorvastatin may cause nightmares. BMJ 2006;332:950. (Pubitemid 44365553)
40. Krahn LE. Psychiatric disorders associated with disturbed sleep. Semin Neurol 2005;25:90-6. (Pubitemid 40471629)
41. Roux FJ, Kryger MH. Medication effects on sleep. Clin Chest Med 2010;31:397-405.
42. Avorn J, Schneeweiss S, Sudarsky LR et al. Sudden uncontrollable somnolence and medication use in Parkinson disease. Arch Neurol 2005;62:1242-8. (Pubitemid 41168351)
43. Khatami R, Siegal AM, Bassetti CL. Hypersomnia in an epilepsy patient treated with levetiracetam. Epilepsia 2005;46: 588-9. (Pubitemid 40470685)
44. Zasiewicz TA, Hauser RA. Sleep attacks and dopamine agonists for Parkinson's disease: what is currently known? CNS Drugs 2003;17:593-600.
45. Homann CN, Wenzel K, Suppan K et al. Sleep attacks in patients taking dopamine agonists: review. BMJ 2002;324:1483-7. (Pubitemid 34666614)
46. Bares M, Kanovsky P, Rektor I. Excessive daytime sleepiness and sleep attacks induced by entacapone. Fundam Clin Pharmacol 2003;17:113-6. (Pubitemid 36241459)
47. Ferreira JJ, Galitzky M, Montastruc JL et al. Sleep attacks and Parkinson's disease treatment. Lancet 2000;335:1333.
48. Plowman BK, Boggie DT, Morreale AP et al. Sleep attacks in patients receiving dopamine-receptor agonists. Am J Health Syst Pharm 2005;62:537-40. (Pubitemid 40332267)
49. Garcia-Borreguero D, Schwarz C, Larrosa O et al. L-DOPAinduced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment. Neurology 2003;61:1008-10. (Pubitemid 37248668)
50. Kupfer DJ, Reynolds CF. Management of insomnia. N Engl J Med 1997;336:341-6. (Pubitemid 27057186)
51. Sullivan SS. Insomnia pharmacology. Med Clin North Am 2010;94:553-8.
52. Gray J, Young B. Acute onset insomnia associated with the initiation of raltegravir: a report of two cases and literature review. AIDS Patient Care STDs 2009;23:689-90.
53. Schenck CH, Mahawold MW. Rapid eye movement sleep parasomnias. Neurol Clin 2005;23:1107-26. (Pubitemid 41503067)
54. Dolder CR, Nelson MH. Hyposedative-induced complex behaviours. CNS Drugs 2008;22:1021-36.
55. U.S. Food and Drug Administration. FDA requests label change for all sleep disorder drug products. Available at http://www.fda.gov/newsevents/ newsroom/pressannouncements/2007/ucm108868.htm. Accessed June 30, 2010.
56. Kolivakis TT, Margolese HC, Beauclair L et al. Olanzapineinduced somnambulism. Am J Psychiatry 2001;158:1158.
57. Hafeez ZH, Kalinowski CM. Somnambulism induced by quetiapine: two case reports and a review of the literature. CNS Spectr 2007;12:910-2.
58. Hoque R, Chesson AL. Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-fluorodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem. J Clin Sleep Med 2009;5:471-6.
59. Hensel J, Pillmann F. Late-life somnambulism after therapy with metoprolol. Clin Neuropharmacol 2008;31:248-50.
60. Yeh YW, Chen CH, Feng HM et al. New onset somnambulism associated with different dosage of mirtazapine: a case report. Clin Neuropharmacol 2009;32:232-3.